ABSTRACT To delineate the role of proteoglycans in turkey skeletal muscle development, proteoglycan expression was examined in pectoral muscle from 14-, 20-, and 25-d-old embryos. Proteoglycans were separated by DEAE (diethylaminoethyl cellulose) anion exchange and molecular sieve chromatography. Glycosaminoglycan composition was measured by enzyme digestion and nitrous acid deamination. The proteoglycan decorin was analyzed at each of these stages of development for core protein size by polyacrylamide gel electrophoresis and for spatial distribution by immunohistochemistry. Chondroitin sulfate-containing proteoglycans were the predominant proteoglycans found throughout turkey em-
INTRODUCTION
Skeletal muscle myogenesis is a highly organized process regulated by complex interactions between muscle cells and their environment. Muscle develops from myoblasts that proliferate, align, and fuse to form multinucleated myotubes that differentiate into mature muscle fibers. Muscle fibers are surrounded and supported by three layers of connective tissue: endomysium, perimysium, and epimysium. Connective tissue is composed of cells and an extracellular matrix (ECM). The ECM is composed of fibrous and nonfibrous proteins including collagens and proteoglycans. Proteoglycans participate in a variety of biological processes including cell migration, cell adhesion, and growth factor regulation (Yanagishita, 1993) . In skeletal muscle, chondroitin sulfate, dermatan sulfate, and heparan sulfate proteoglycans have been identified (Young et al., 1989; Fernandez et al., 1991; Brandan and Larrain, 1998) . Fernandez et al. (1991) have shown that the ECM is a complex structure and that proteoglycan expression 1 Salaries and research support provided by state and federal funds appropriated to the Ohio Agricultural Research and Development Center, The Ohio State University. 2 To whom correspondence should be addressed: velleman.1@osu.edu 1619 bryonic skeletal muscle development. However, in 20-and 25-d-old pectoral muscle, higher levels of heparan and dermatan sulfate were observed compared with their values at 14 d. Two decorin core protein bands with molecular weights of 45 and 46 kDa were detected. Immunostaining for decorin showed that, as the connective tissue layers developed, decorin was localized in the perimysium and epimysium. These data indicate that turkey embryonic skeletal muscle proteoglycan expression is dynamic and changes from a matrix that is rich in a large chondroitin sulfate proteoglycan to one containing dermatan sulfate, heparan sulfate, and chondroitin sulfate proteoglycans, and suggests the presence of two forms of decorin.
changes during chicken skeletal muscle development. As muscle proceeds through embryonic maturation, a transition from a chondroitin sulfate-rich matrix into a complex matrix containing chondroitin sulfate, dermatan sulfate, and heparan sulfate proteoglycans occurs (Young et al., 1989) . These results suggest that different proteoglycans may have distinct roles during skeletal muscle differentiation. Furthermore, each of the different classes of proteoglycans found in skeletal muscle has unique functions.
For example, the chondroitin sulfate proteoglycan, versican, has been identified in numerous tissues, including skeletal muscle Carrino et al., 1994) . High levels of versican have been reported during early stages of chicken skeletal muscle myogenesis (Carrino and Caplan, 1984) and in regenerating muscle (Carrino et al., 1988) . The dermatan sulfate proteoglycan, decorin, is a multifunctional proteoglycan affecting collagen fibrillogenesis (Vogel et al., 1984; Vogel and Trotter, 1987; Weber et al., 1996) , cell proliferation (Santra et al., 1995; Moscatello et al., 1998) , and transforming growth factor-β activity (Yamaguchi et al., 1990) . Decorin has been detected in skeletal muscle from other species (Brandan et al., 1991; Eggen et al., 1994) , including chicken (Lennon et al., 1991) . Heparan sulfate proteoglycans are localized to the cell surface and basement membrane. Heparan sulfate proteoglycans may regulate the binding of fibroblast growth factor (FGF) to its high-affinity cell signaling receptor (Brandan and Larrain, 1998) . Fibroblast growth factor is a stimulator of muscle cell proliferation and an inhibitor of differentiation (Dollenmeier et al., 1981) .
To date, little information regarding turkey skeletal muscle ECM proteoglycan expression has been reported. In the current study, the types of proteoglycans expressed during turkey embryonic skeletal muscle development at 14, 20, and 25 d were determined. These stages were selected because they would highlight any dynamic expression of proteoglycans from an early to a late embryonic extracellular environment. Because the proteoglycan decorin plays key roles in regulating cell proliferation, growth factor activity, and collagen organization, its expression and distributional pattern were examined.
MATERIALS AND METHODS

Proteoglycan Radioisotopic Labeling
The pectoralis major muscle was dissected from 14-, 20-, and 25-d F-line turkey embryos (Nestor, 1984) (n = 10 to 20 embryos per labeling) with all visible skin and fat removed. Radiolabeling for each developmental stage was done three times. The F line is an experimental turkey line selected long-term for increased 16-wk body weight. After rinsing with sterile PBS (0.17 M NaCl, 3 mM KCl, 0.01 M Na 2 HPO 4 , 2 mM KH 2 PO 4 ; pH 7.0), the dissected muscle was minced into small pieces and placed in 0.1% gelatincoated culture dishes (100 × 15 mm) at a density of 1 g tissue per dish. Each culture dish contained 5 mL . The plates were incubated overnight at 37 C in a 95% air/5% CO 2 environment.
Proteoglycan Extraction
The radiolabeled tissue was placed overnight in 4 M guanidine hydrochloride (GuHCl)/0.05 M sodium acetate (NaAc) buffer, pH 5.8 (Sajdera and Hascall, 1969) , containing protease inhibitors (Oegema et al., 1979) at a concentration of 1 g tissue/10 mL buffer, and stirred gently at 4 C. The extracts were clarified by centrifugation at 3,220 × g for 15 min at 4 C. The supernatants were collected. The incorporated radioactivity was separated from unincorporated radioisotope by Sephadex G-50 chromatography (15 × 10 cm) and eluted with 4 M GuHCl/0.05 M NaAc buffer (V o ) fractions were pooled, dialyzed against nanopure 5 water overnight at 4 C, and lyophilized.
Proteoglycan Isolation by Ion-Exchange Chromatography
Proteoglycans were isolated by DEAE (diethylaminoethyl cellulose) anion exchange chromatography based on the method of Yanagishita and Hascall (1983) . Approximately 1 × 10 6 cpm was applied to each DEAE-Sephacel 6 anion-exchange column (10 × 1.0 cm) and eluted with 60 mL elution buffer (8 M urea and 0.05 M NaCl; pH 7.0) containing a linear NaCl gradient from 0.25 to 1.0 M (Carrino et al., 1994) . The flow rate was 0.5 mL/min, and fractions of 1 mL were collected. The optical density (OD) at 280 nm, conductivity, and radioactivity in cpm of each fraction were measured. The elution profile was graphed as the OD 280 nm, percentage of total cpm (percentage total cpm = cpm of each fraction per total cpm), and conductivity. Fractions were pooled according to their radioactive profile.
Molecular Sieve CL-2B Gel Filtration Chromatography
Pooled DEAE samples were applied to a Sepharose CL-2B column (110 × 0.6 cm) and eluted with 4 M GuHCl/ 0.05 M NaAc buffer (pH 5.8) at a flow rate of 0.5 mL/min. Fractions of 0.5 mL were collected. The radioactivity of each fraction in cpm was measured.
Glycosaminoglycan Removal from the Proteoglycan Core Protein
Glycosaminoglycans were released from the core protein by alkaline borohydride treatment (Lohmander et al., 1979) . In brief, each pooled sample from the CL-2B chromatography was dialyzed, lyophilized, resuspended in 300 µL nanopure H 2 O, and incubated at 45 C for 48 h in 300 µL NaBH 4 solution (75.5 mg NaBH 4 /mL in 0.1 M NaOH). After the incubation, the reaction was terminated by adding HAc to each sample to a final pH of 7.0.
Glycosaminoglycan Analysis
Glycosaminoglycan analysis was modified from the methods of Noonan et al. (1986) and Velleman et al. (1996) . In brief, after alkaline borohydride treatment to release the glycosaminoglycans from the core protein, the samples were dialyzed against distilled H 2 O, a 20-µL aliquot was counted for radioactivity, and each sample was divided into four aliquots containing equal amounts of radioactivity and treated with chondroitinase ABC, chondroitinase B, nitrous acid, or without any treatment. Chondroitinase ABC digests both chondroitin and dermatan sulfate. Chondroitinase B digests only dermatan sulfate, whereas nitrous acid deamination removes heparan sulfate. The untreated and chondroitinase B digestion samples were resuspended in 600 µL 20 mM Tris-HCl, 50 mM NaCl, 4 mM CaCl 2 , and 0.01% BSA (pH 7.0). The chondroitinase B digestion was done at an enzyme concentration of 1 unit/mL at 25 C for 17 h. Chondroitinase ABC digestion samples were resuspended in 600 µL 250 mM Tris-HCl, 350 mM NaCl, and 0.05% BSA (pH 8.0), and incubated with 1 unit/mL chondroitinase ABC at 37 C for 17 h. Nitrous acid deamination samples were resuspended in 600 µL nanopure H 2 O and treated with 75 µL HAc and 75 µL 18% NaNO 2 at 25 C for 80 min. The reaction was stopped by adding 750 µL 2 M NH 4 (SO 2 )NH 2 for 30 min. Each sample was applied to a Sepharose CL-6B column (110 × 0.6 cm) and eluted with 4 M GuHCl/0.05 M NaAc buffer (pH 5.8) at a flow rate of 0.5 mL/min. Fractions of 0.5 mL were collected, and the radioactivity of each fraction in cpm was measured. The percentage digestion after each treatment was calculated by comparing radioactivity remaining after digestion to the undigested control. Because chondroitinase ABC digests both chondroitin sulfate and dermatan sulfate, the chondroitin sulfate values were obtained by subtracting the value of the chondroitinase B digestion from the value of the chondroitinase ABC digestion.
Western Blot Analysis
A total of 1.5 g pectoral muscle tissue from 14-, 20-, and 25-d embryos was extracted with GuHCl as previously described. The samples were separated by DEAE anion exchange and Sepharose CL-2B chromatography and pooled. After treatment with chondroitinase ABC, chondroitinase B, nitrous acid deamination, and, for undigested controls, the samples were resuspended in 50 µL 1% SDS, 10% glycerol, 1% β-mercaptoethanol, 0.1 M Tris-HCl, and 0.1% (wt/vol) bromophenol blue (pH 6.8) and heated at 65 C for 10 min. Samples were applied to a SDS-polyacrylamide gel based on the method of Laemmli (1970) containing a linear gradient of polyacrylamide from 5 to 17.5% in the separating gel and a 3.2% stacking gel. Electrophoresis was run in a 25 mM Tris-HCl, 1.90 M glycine, and 0.1% sodium dodecyl sulfate (pH 8.4) running buffer at 20 mAmps constant current while the samples were in the stacking gel and at 30 mAmps during the separation phase. After electrophoresis, the proteins were electrophoretically transferred to nitrocellulose 7 at 25 mAmps constant current for 5 h at 4 C based on the method of Towbin et al. (1979) . The transfer buffer contained 25 mM Tris-HCl, 192 mM glycine, and 10% (vol/vol) methanol (pH 8.3). Color development was done according to the method of Velleman (1995) . In brief, the membrane was air-dried for 17 h and blocked in 100 mL 3% gelatin in 1× Tris-buffered saline (20 mM Tris-HCl, 500 mM NaCl; pH 7.5; TBS) for 1 h at 37 C with gentle shaking (60 rpm). After washing three times in 100 mL 0.05% Tween 20 in 1× TBS (pH 7.5; 1× TTBS) for 5 min each, the membrane was incubated in chicken decorin monoclonal antibody (1:200 in 1% gelatin in 1× TBS) (Lennon et al., 1991) for 3 to 4 h at room temperature and then washed three times in 100 mL 1× TTBS for 5 min each. The blot was then incubated in alkaline phosphatase conjugated goat antimouse IgG 7 (1:3000 in 1% gelatin in 1× TBS) for 2 h at room temperature. The membrane was washed two times in 100 mL 1× TTBS and one time in 100 mL 1× TBS with 15 min per wash. Color was developed by adding 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium 8 solution. The blot was scanned and analyzed with a PDI Quantity One scanner 9 , and the molecular weight of each band was determined.
Immunolocalization of Decorin
Pectoral major muscle tissue was dissected from 14-, 20-, and 25-d-old embryos and quick frozen in liquid nitrogen cooled isopentane. The muscle tissue was then fixed in 95% EtOH/5% glutaraldehyde and stored at −70 C. After dehydrating through a graded series of alcohols and xylene, the tissue was embedded in paraffin, and 6-µm cross-sections were mounted on sodium silicate-coated slides. After rehydrating, the sections were digested with 0.25 units chondroitinase ABC per slide at 37 C for 4 h in a Boekel Scientific slide moat 10 . The slides were rinsed with running tap water for 5 min and washed three times with 1× TBS for 1 min each. After washing, the sections were covered with 10% goat serum 11 in 1× TBS with 1% BSA and incubated for 1 h at room temperature. At the end of the incubation, the goat serum was removed by gentle blotting and the slides were then covered with 200 µL chicken decorin monoclonal antibody (1:100 in 1× TBS containing 1% BSA) (Lennon et al., 1991) at 4 C for 17 h. Negative control slides that did not include the primary antibody for decorin were also processed in the 1× TBS solution containing 1% BSA. The slides were then washed twice for 10 min each in 1× TBS and once for 10 min in 1× TBS containing 0.5% BSA. After washing, the slides were incubated at room temperature for 2 h in a 1:25 rabbit anti-mouse IgG 12 in 1× TBS containing 1% BSA. The slides were washed once for 5 min in 1× TBS, once for 10 min in 1× TBS, and once for 10 min in 1× TBS containing 0.5% BSA and then incubated in 1:50 monoclonal mouse peroxidase-anti-peroxidase 12 in 1× TBS containing 1% BSA. The slides were washed three times for 10 min each in 1× TBS and once for 5 min in nanopure H 2 O and stained with diaminobenzadine 8 (6 mg diaminobenzadine/10 mL 0.05 M Tris-HCl; pH 7.6; prepared fresh with 100 µL 3% hydrogen peroxide added immediately before staining the slides). Color development was stopped by placing the slides under running tap water. Staining was viewed with an Olympus IX 70 13 microscope and photographed with Kodak Ektachrome 200 film.
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Statistical Analysis
The general linear model procedure of SAS Institute (1985) was used to estimate the differences among the different treatments of samples within the same developmental stage using a randomized complete block model. The DEAE Pool 2 and 3 samples were analyzed separately. Differences were considered significant at P < 0.05.
RESULTS
Ion-Exchange Chromatography and Molecular Sieve Separation of Skeletal Muscle Proteoglycans
Diethylaminoethyl cellulose-Sephacel anion exchange chromatography was used to isolate turkey skeletal muscle proteoglycans. Two major peaks of radioactivity eluted from the 14-, 20-, and 25-d-old embryo extracts (Figure 1 ). The first peak eluted from Fractions 4 to 15 (NaCl range = 0.25 to 0.33 M; conductivity=17 to 20 mmhos). This peak was collected as DEAE Pool 1 and contained a low amount of radioactivity and a high level of protein. The second peak ranged from Fractions 30 to 60 (NaCl = 0.46 to 1.0 M, conductivity 23 to 45 mmhos). This peak contained a lower amount of protein but the majority of [ 35 S]-SO 4 incorporation. This peak, as reported in other investigations (Carrino et al., 1994) , contains the proteoglycans because of the high negative charge, large amount of sulfate groups, and relatively small amount of protein. The second peak was collected into two pools and further analyzed for glycosaminoglycan composition. Fractions 30 to 47 were collected as DEAE Pool 2, and Fractions 48 to 60 were collected as DEAE Pool 3. Pool 2 eluted with a NaCl range of 0.46 to 0.63 M, and Pool 3 eluted with a NaCl range of 0.66 to 1.0 M.
The DEAE Pool 2 sample was chromatographed on a Sepharose CL-2B column to determine molecular sieve properties. The DEAE Pool 2 sample from 14-d-old embryos resulted in two peaks after CL-2B chromatography (Figure 2A) . The first peak ranged from Fractions 20 to 30 (K av = 0 to 0.31), containing the V o volume. The second peak was from Fractions 41 to 60 (K av = 0.66 to 1.0). Fractions 18 to 27 (K av = 0 to 0.22), 28 to 36 (K av = 0.25 to 0.5), 37 to 46 (K av = 0.53 to 0.81), and 47 to 60 (K av = 0.84 to 1.0) were pooled as DEAE Pool 2, CL-2B 1, 2, 3, and 4, respectively.
The DEAE Pool 2 sample from 20-d-old embryonic pectoral muscle, when chromatographed on a Sepharose CL-2B column, resulted in two peaks ( Figure 2B) . However, the V o peak was smaller when compared with that from 14-d-old embryos. Fractions 18 to 27 (K av = 0 to 0.22), 28 to 36 (K av = 0.25 to 0.5), 37 to 46 (K av = 0.53 to 0.81), and 47 to 60 (K av = 0.84 to 1.0) were pooled as CL-2B 1, 2, 3, and 4, respectively.
The Sepharose CL-2B elution profile for DEAE Pool 2 from embryonic 25-d pectoral muscle was similar to that of the 20-d embryonic muscle in that there was a small V o FIGURE 2. Diethylaminoethyl cellulose (DEAE) Pool 2 samples from A) 14-d-old embryos, B) 20-d-old embryos, and C) 25-d-old embryos were separated by molecular sieve Sepharose CL-2B chromatography. The V o was at Fraction 20, and the V t was at Fraction 52. Fractions were pooled as indicated for glycosaminoglycan analysis. peak and a relatively large peak in the separating range ( Figure 2C ). Fractions 18 to 27 (K av = 0 to 0.22), 28 to 36 (K av = 0.25 to 0.5), 37 to 46 (K av = 0.53 to 0.81), and 47 to 60 (K av = 0.84 to 1.0) were pooled as CL-2B 1, 2, 3, and 4, respectively.
The DEAE Pool 3 sample from the 14-d embryonic pectoral muscle had a large V o peak and several small peaks between the V o and V t ( Figure 3A) . Fractions 18 to 30 (K av = 0 to 0.31), 31 to 42 (K av = 0.34 to 0.69), and 43 to 60 (K av = 0.72 to 1.0) were collected into three pools, termed DEAE Pool 3, CL-2B 1, 2, and 3, respectively.
The 20-d embryonic pectoral muscle DEAE Pool 3 had a different elution pattern than that of the 14-d samples ( Figure 3B ). The V o peak was small, and the predominant peak was located from Fractions 30 to 60. The DEAE Pool 3 sample extracted from 25-d-old embryos had no detectable V o peak after CL-2B chromatography ( Figure 3C ). Only a large peak ranging from Fractions 18 to 60 was detected. Fractions 18 to 30 (K av = 0 to 0.31), 31 to 36 (K av = 0.34 to 0.5), 37 to 45 (K av = 0.53 to 0.78), and 46 to 60 (K av = 0.81 to 1.0) were pooled as CL-2B 1, 2, 3, and 4, respectively.
The elution data showed that both DEAE Pools 2 and 3 from 14-d embryonic pectoral muscle had a large V o peak. In contrast, the samples from 20-and 25-d-old embryos had only a very small or no V o peak, which indicated that the 14 embryonic-d turkey pectoral muscle contained larger proteoglycans than the other two later stages.
Glycosaminoglycan Composition
The percentage chondroitin sulfate, dermatan sulfate, and heparan sulfate present in 14-, 20-, and 25-d embryonic pectoral muscle was measured. At Day 14 of embryonic development, both DEAE Pool 2 and 3 samples showed high sensitivity to chondroitinase ABC digestion, with the DEAE pool 2 and 3 CL-2B 1 fractions containing greater than 90% chondroitin sulfate (Table 1) . Dermatan and heparan sulfate levels were much lower, with maximum dermatan and heparan sulfate levels in the DEAE 2 CL-2B 4 and DEAE 3 CL-2B 3 fractions (Table 1) .
At Day 20 of embryonic development, the sensitivity to chondroitinase-B digestion and nitrous acid deamination was increased, indicating an increase in dermatan and heparan sulfate (Table 2 ). Dermatan and heparan sulfate levels were maximal in the CL-2B 2, 3, and 4 fractions compared with the CL-2B 1 fraction. Chondroitin sulfate levels were maximal in the DEAE Pools 2 and 3 CL-2B 1 fractions that contained larger molecules.
The glycosaminoglycan composition of 25-d embryonic pectoral muscle (Table 3 ) contained higher dermatan sul- Percentages within diethylaminoethyl sephacel (DEAE) pools with no common letter are different (P ≤ 0.05).
1 Samples were digested with chondroitinase ABC, chondroitinase B, or nitrous acid deamination. Chondroitinase ABC digests both chondroitin sulfate and dermatan sulfate. Chondroitinase B digests only dermatan sulfate, whereas nitrous acid deamination removes heparan sulfate. Diethylaminoethyl sephacel pools 2 and 3 were statistically analyzed separately.
fate and heparan sulfate compared with that of 14-d-old embryos (Table 1) , but similar to the 20-d embryonic profile (Table 2 ). The 25-d DEAE Pool 2 chondroitin sulfate composition continued to decrease, whereas DEAE Pool 3 levels were similar to those at embryonic Day 14 and 20.
Identification and Distribution of Decorin
Decorin was identified in DEAE Pools 2 and 3 at all developmental stages examined in this study. However, decorin was not detected in DEAE Pools 2 and 3, CL-2B 1 samples at any developmental stages. This result corresponds to the molecular sieve data showing that the CL-2B 1 samples contain predominantly large proteoglycans, whereas decorin is a relatively small proteoglycan. At all stages of development analyzed in this study, bands of 46 and 45 kDa were immunoreactive to the decorin antibody after chondroitinase ABC digestion (Figure 4) . However, some of the pooled fractions only contained the 45-kDa band. The 46-kDa band was not observed independent of the 45-kDa band. In the undigested control, a wide band of approximately 130 kDa was observed, which most likely represents undigested decorin.
The temporal and spatial distribution of decorin was determined by immunohistochemistry. At Day 14 of embryonic development, the pectoral muscle bundles and connective tissue layers were not well developed ( Figure  5A ). Decorin exhibited a pericellular distribution. At Day 20, the perimysium and epimysium connective tissue layers were formed, and decorin was observed in both of these layers ( Figure 5B ). At Day 25 of development, decorin was still detected in both the perimysium and epimysium ( Figure 5C ); however, it was predominantly located in the epimysium, whereas at Day 20 the staining was more intense in the perimysium.
DISCUSSION
The results of the present study demonstrated that turkey skeletal muscle proteoglycans are expressed in a dynamic pattern similar to that observed in the chicken (Fernandez et al., 1991) and the mouse (Young et al., 1990) . It is possible that this expression pattern during myogenesis is conserved in different animals, which suggests that different proteoglycans may have distinct functions at specific stages during myogenesis.
The high percentage of large chondroitin sulfate proteoglycans in DEAE Pool 2 at Day 14 of embryonic development suggests that this proteoglycan type may play a key role in early myogenic processes. Although the precise function of the large chondroitin sulfate proteoglycans is unknown, Fernandez et al. (1991) have postulated that these proteoglycans, which are highly negative in charge because of the large amount of sulfate groups in their glycosaminoglycan chains, may draw water into the developing muscle tissue through ionic interactions. The water creates an extracellular space that is critical for the cell migrations necessary for myoblast alignment and the spacing of muscle fibers. In support of this hypothesis, the versican PG, which is a large chondroitin sulfate proteoglycan, has been shown by Velleman et al. (1997) to be expressed at high levels in 15-d embryonic turkey pectoral muscle and decrease with further embryonic development.
The DEAE Pool 3 chondroitin sulfate proteoglycans did not exhibit significant percentile changes at the developmental stages examined in this study. These data are suggestive of more than one population of chondroitin sulfate proteoglycans in turkey skeletal muscle. In support of this possibility, Carrino and Caplan (1984) isolated a large chicken skeletal muscle chondroitin sulfate proteoglycan that has a lower proportion of 6-sulfate chondroitin sulfate and smaller chondroitin sulfate chain length than the proteoglycan versican. The developmental expression and characterization of these chondroitin sulfate proteoglycans still remains to be elucidated.
The expression of heparan sulfate proteoglycans increased with turkey skeletal muscle development. In skeletal muscle, heparan sulfate proteoglycans are located in the basement membrane and at the cell surface. With the rapid growth of turkey skeletal muscle toward the end of embryonic development, the basement membrane will increase in size. This size increase will likely increase basement membrane levels of heparan sulfate proteoglycans. Furthermore, the cell surface heparan sulfate proteoglycan, glypican, is upregulated during muscle differentiation in the mouse (Brandan et al., 1996) .
The expression of dermatan sulfate proteoglycans increased with skeletal muscle development. The chondroitin/dermatan sulfate proteoglycan, decorin, was detected at all embryonic developmental stages examined in this study. The present results suggest the possibility of two different forms of decorin in embryonic turkey skeletal muscle, one with a 45-kDa core protein and the other a 46-kDa core protein. Roughley et al. (1996) reported a proform of decorin that contains 14 more amino acids and is approximately 1 kDa larger than the mature decorin core protein in human cartilage. It is possible that embryonic turkey skeletal muscle contains both a mature and proform of decorin. The temporal and spatial distribution of decorin corresponds to the formation of the different muscle connective tissue layers. This expression pattern may be due to decorin's role in regulating collagen fibrillogenesis (Vogel et al., 1984; Vogel and Trotter, 1987; Weber et al., 1996) . Collagen is the predominant ECM macromolecule, and its fibril structure is related to tissue functional properties such as elasticity. Skeletal muscle collagen is found at high levels in the epimysium and perimysium connective tissue layers (McCormick, 1994) .
The proteoglycan expression pattern observed during turkey embryonic skeletal muscle development provides further insight into the developmental regulation of proteoglycans during skeletal muscle myogenesis. A comprehensive knowledge of proteoglycan expression during myogenesis is necessary to understand ECM regulation of skeletal muscle growth and development.
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